Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer

JEA Portielje; Wim Kruit; M Schuler; J Beck; CHJM Lamers; Gerrit Stoter; C Huber; M Boer-Dennert; A Rakhit; RLH (Reinder) Bolhuis; WE Aulitzky

Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer

JEA Portielje, Wim Kruit, M Schuler, J Beck, CHJM Lamers, Gerrit Stoter, C Huber, M Boer-Dennert, A Rakhit, RLH (Reinder) Bolhuis, WE Aulitzky

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

103 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3983-3989
Number of pages	7
Journal	Clinical Cancer Research
Volume	5
Publication status	Published - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{a8278141013440bcb73aec3194c47027,

title = "Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer",

author = "JEA Portielje and Wim Kruit and M Schuler and J Beck and CHJM Lamers and Gerrit Stoter and C Huber and M Boer-Dennert and A Rakhit and Bolhuis, {RLH (Reinder)} and WE Aulitzky",

year = "1999",

language = "Undefined/Unknown",

volume = "5",

pages = "3983--3989",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer

AU - Portielje, JEA

AU - Kruit, Wim

AU - Schuler, M

AU - Beck, J

AU - Lamers, CHJM

AU - Stoter, Gerrit

AU - Huber, C

AU - Boer-Dennert, M

AU - Rakhit, A

AU - Bolhuis, RLH (Reinder)

AU - Aulitzky, WE

PY - 1999

Y1 - 1999

M3 - Article

VL - 5

SP - 3983

EP - 3989

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

ER -